Quest Diagnostics expects 2026 earnings to beat estimates behind strong test demand
Quest Diagnostics projects 2026 results above analyst expectations following a strong fourth quarter. Rising demand for lab tests is fueling company growth.
洞察:
Quest Diagnostics Incorporated reported on February 10, 2026, that it beat fourth-quarter analyst estimates and issued 2026 profit and revenue guidance that exceeded Wall Street forecasts. The company’s stronger-than-expected outlook in the US 
US is driven by materially higher demand for diagnostic testing and increased hospital lab management activity.
US is driven by materially higher demand for diagnostic testing and increased hospital lab management activity.According to the company's announcement, Quest Diagnostics expects 2026 adjusted profit to fall between $10.50 and $10.70 per share. Revenue for the same period is projected to range from $11.7 billion to $11.82 billion. These figures are notably above the analyst averages recorded by LSEG, reflecting a positive shift in the company's near-term financial outlook and market positioning.
